secwatch / observer

Earnings Releases

Quarterly and annual results disclosed under 8-K Item 2.02.

8-K items 2.02 JSON
BRC BRADY CORP

BRADY CORP reported the full year ending July 31, 2026 results: EPS Adjusted Diluted EPS* Guidance was raised for the full year ending July 31, 2026 from the previous range of $4.95 to $5.. Guidance raised.

“Adjusted Diluted EPS* Guidance was raised for the full year ending July 31, 2026 from the previous range of $4.95 to $5.15 per share to the new range of $5.20 to $5.30 per share”
BRC BRADY CORP

BRADY CORP reported the nine-month period ended April 30, 2026 results: revenue $1.22 billion, net income $159.8 million, EPS $3.35. Guidance raised.

“of 4.3 percent, growth of 2.5 percent from acquisitions and an increase of 2.9 percent from foreign currency translation. Sales for the nine months ended April 30, 2026 were $1.22 billion compared to $1.12 billion in the same period last year. By region, sales increased 10.6 percent in the Americas & Asia and sales increased 8.0 percent in Europe & Australia,”
BRC BRADY CORP

BRADY CORP reported its fiscal 2026 third quarter ended April 30, 2026 results: revenue $435.2 million, net income $57.8 million, EPS $1.21. Guidance raised.

“growth of 8.2 percent, growth of 2.1 percent from acquisitions and an increase of 3.5 percent from foreign currency translation. Sales for the quarter ended April 30, 2026 were $435.2 million compared to $382.6 million in the same quarter last year. By region, sales increased 14.4 percent in the Americas & Asia and sales increased 12.6 percent in Europe & Australia,”
SQFT Presidio Property Trust, Inc.

Presidio Property Trust, Inc. reported the quarter ended March 31, 2026 results: revenue approximately $3.8 million, net income approximately $(129,632), EPS $(0.10) per basic and diluted share.

“share for the three months ended March 31, 2025. The change in net income attributable to the Company’s common stockholders was a result of: ● Total revenues were approximately $3.8 million for the three months ended March 31, 2026, compared to approximately $4.1 million for the same period in 2025. As of March 31, 2026, we had approximately $100.5 million in net”
RAMP LiveRamp Holdings, Inc.

LiveRamp Holdings, Inc. reported financial results for fourth quarter and fiscal year ended March 31, 2026.

“announcing the results of its financial performance for its fourth quarter and fiscal year ended March 31, 2026”
OTLK Outlook Therapeutics, Inc.

Outlook Therapeutics, Inc. reported second fiscal quarter ended March 31, 2026 results: net income net loss attributable to common stockholders of $4.5 million, or $0.05 per basic and diluted share.

“Outlook Therapeutics reported net loss attributable to common stockholders of $4.5 million, or $0.05 per basic and diluted share.”
AGPU Axe Compute Inc.

Axe Compute Inc. reported first quarter ended March 31, 2026 results: revenue $35 thousand, net income $7.7 million, EPS $0.36 per share.

“FIRST QUARTER 2026 FINANCIAL HIGHLIGHTS Total Revenue: $35 thousand in Q1 2026, compared to $110 thousand in Q1 2025. The Q1 2026 sales primarily reflects sales from the legacy Drug Discovery Services segment, with $7 thousand contributed by the Compute Services segment reflecting a handful of initial contract deployments that commenced in late March 2026 and will contribute revenue over the respective contract service periods beyond March 31, 2026.”
DYNR DYNARESOURCE, INC.

DYNARESOURCE, INC. reported the three months ending March 31, 2026 results: revenue $18.0 million, net income $2.5 million.

“Q1 2026 Highlights: • Revenue for Q1 2026 totaled $18.0 million, up 31% over $13.7 million in Q1 2025 and up 22% over $14.8 million in Q4 2025 • Q1 2026 Net Income of $2.5 million was up significantly from $0.6 million in Q1 2025 and $1.4 million in Q4 2025 • Sixth consecutive quarter of positive adjusted EBITDA with $6.0 million in Q1 2026, up 161% from $2.3 million in Q1 2025 and up 28% from $4.7 million in Q4 2025 • Gold production of 4,840 ounces was down 16% from 5,781 ounces in Q1 2025 and 5% from 5,080 ounces in Q4 2025 • Milled throughput of 69,816 tons in Q1 2026 was up 4% from 67,374 tons in Q1 2025 and 7% from 65,275 tons in Q4 2025 • Daily mill throughput average of 767 tonnes per day, up 4% from 740 tons per day in Q1 2025 and up 8% from 710 tons per day in Q4 2025 • Head grade of 2.90 g/t gold was down compared to both comparative quarters “ Results from the first quarter r”
FET FORUM ENERGY TECHNOLOGIES, INC.

FORUM ENERGY TECHNOLOGIES, INC. reported Full Year 2026 results: revenue $800 - $880 million, net income $18 - $38 million. Guidance initiated.

“Full Year 2026 Guidance (comparisons at midpoint) • Revenue: $800 - $880 million, up 6% • Adjusted net income: $18 - $38 million, up $21 million • Adjusted EBITDA: $90 - $110 million, a 16% increase • Free cash flow: $55 - $75 million, 65% free cash flow conversion”
FET FORUM ENERGY TECHNOLOGIES, INC.

FORUM ENERGY TECHNOLOGIES, INC. reported the quarter ended December 31, 2025 results: revenue $202.2 million, net income $2.1 million or $0.17 per diluted share, EPS $0.17 per diluted share. Guidance initiated.

“Forum Energy Technologies, Inc. (NYSE: FET) today announced fourth quarter 2025 revenue of $202.2 million and net income of $2.1 million or $0.17 per diluted share.”
HURA TuHURA Biosciences, Inc./NV

TuHURA Biosciences, Inc./NV reported financial results for three months ended March 31, 2026.

“Summary of Financial Results for the First Quarter 2026 Cash and cash equivalents of $6.3 million at March 31, 2026. TuHURA's total common shares outstanding were approximately 63.6 million. Research and development expenses were $5.2 million and $4.6 million for the 3 months ended March 31, 2026, and 2025, respectively. General and administrative (G&A) expenses were $2.3 million and $2.0 million for the 3 months ended March 31, 2026, and 2025, respectively. Net cash outflows from operating activities were ($4.4) million and ($4.7) million for the 3 months ended March 31, 2026, and 2025, respectively. Net cash flows from financing activities were $ 7.2 million and $ (0.5) million for the 3 months ended March 31, 2026, and 2025, respectively.”
EUBG ENTREPRENEUR UNIVERSE BRIGHT GROUP

ENTREPRENEUR UNIVERSE BRIGHT GROUP reported the three months ended March 31, 2026 results: revenue $737,844, net income $77,879.

“Entrepreneur Universe Bright Group Reports First Quarter 2026 Financial Results XI'AN, China, May 15, 2026 /PRNewswire/ -- Entrepreneur Universe Bright Group ("EUBG" or the "Company"), a Nevada corporation, reported its unaudited financial results for the three months ended March 31, 2026. First Quarter 2026 Financial Highlights - Revenue: $737,844 for the first quarter of 2026, compared to $961,954 for the first quarter of 2025. - Net Income: $77,879 for the first quarter of 2026, compared to $183,485 for the first quarter of 2025.”
ANY Sphere 3D Corp.

Sphere 3D Corp. reported first quarter of FY 2026 ended March 31, 2026 results: revenue $1.9 million, net income $4.1 million, or a net loss of $1.18 per share, EPS $1.18 per share.

“RESULTS • Bitcoin production during the first quarter of 2026 was 25.3 Bitcoin, compared to 30.5 Bitcoin for the first quarter of 2025. • The Company generated revenue of $1.9 million in the first quarter of 2026 compared to $2.8 million in the first quarter of 2025, primarily driven by a decrease in the fair value of Bitcoin during the period. Results were”
SUNE SUNation Energy, Inc.

SUNation Energy, Inc. reported the first quarter ended March 31, 2026 results: revenue $7.2 million, EPS $(1.20) per diluted share.

“results will show what we’ve got what it takes as this market settles out.” Q1 2026 FINANCIAL AND OPERATIONAL RESULTS Financial Results ● Consolidated revenue decreased 43.1% to $7.2 million from $12.6 million, driven primarily by a 53% decrease in residential contract revenue and a 3% decrease in service revenue, partially offset by a 15% increase in commercial”
BCLI BRAINSTORM CELL THERAPEUTICS INC.

BRAINSTORM CELL THERAPEUTICS INC. reported the three months ended March 31, 2026 results: net income Net loss for the three months ended March 31, 2026 was approximately $2.1 million, EPS Net loss per share for the three months ended March 31, 2026 and 2025 was $(0.19) and $(0.45), respectively..

“BrainStorm Cell Therapeutics Inc. issued a press release announcing its financial results for the quarter ended March 31, 2026.”
VUZI Vuzix Corp

Vuzix Corp reported the three months ended March 31, 2026 results: revenue $1.4 million, net income $7.1 million, EPS $0.09 per share.

“For the three months ended March 31, 2026, total revenues decreased by 12% to $1.4 million versus $1.6 million for the comparable period in 2025.”
BEEM Beam Global

Beam Global reported the three months ended March 31, 2026 results: revenue $3.1 million, net income $6.9 million, or $(0.33) per share, EPS $(0.33) per share.

“Revenues for the three months ended March 31, 2026 were $3.1 million”
DAIO DATA I/O CORP

DATA I/O CORP reported first quarter ended March 31, 2026 results: revenue $3.3 million. Guidance raised.

“on an organic basis. Costs are coming down, customer activity is building, and we are executing against a plan that is tracking nearly one year ahead of schedule. Revenue of $3.3 million and continued negative Adjusted EBITDA are consistent with where we are in the recovery curve. What gives us confidence in the trajectory is the demand environment: customer”
CTOR CITIUS ONCOLOGY, INC.

CITIUS ONCOLOGY, INC. reported the fiscal second quarter ended March 31, 2026 results: revenue $1.7 million.

“revenue milestones; and, ○ approximately $11.5 million in gross proceeds received May 5, 2026 from the exercise of certain outstanding warrants; and, ● Net product revenues of $1.7 million for the three months ended March 31, 2026, compared to no revenue for the three months ended March 31, 2025; and $5.6 million for the six months ended March 31, 2026, compared”
RDI READING INTERNATIONAL INC

READING INTERNATIONAL INC reported First Quarter ended March 31, 2026 results: net income Net Loss Attributable to Reading of $8.1 million, EPS Basic Loss per Share of $0.36.

“Australia, and New Zealand, today announced its results for the First Q uarter ended March 31, 2026 .  Key Financial Summary Results – First Quarter 2026  · Total Revenues of $45.1 million increased by 12% from $40.2 million in Q 1 202 5 . · Representing the best result for this metric since Q1 2019, a reported Operating Loss of $3.6 million marks a 47% improvement”
CTXR Citius Pharmaceuticals, Inc.

Citius Pharmaceuticals, Inc. reported fiscal second quarter ended March 31, 2026 results: revenue Net product revenues of $1.7 million for the three months ended March 31, 2026.

“Net product revenues of $1.7 million for the three months ended March 31, 2026”
MLP MAUI LAND & PINEAPPLE CO INC

MAUI LAND & PINEAPPLE CO INC reported financial results for quarter ended March 31, 2026.

“On May 15, 2026, the Company issued a press release, which sets forth the results of its operations for the quarter ended March 31, 2026.”
CTGO Contango Silver & Gold Inc.

Contango Silver & Gold Inc. reported the quarter ended March 31, 2026 results: net income a net loss of $14.3 M. Guidance reaffirmed.

“Contango Announces Results for the Quarter Ended March 31, 2026”
BOXL Boxlight Corp

Boxlight Corp reported first quarter ended March 31, 2026 results: revenue $22.4 million, net income $(6.5) million, EPS $(2.25).

“interactive technology solutions, today announced the Company’s financial results for the first quarter ended March 31, 2026. Financial and Operational Highlights: • Revenue was $22.4 million for the quarter, an increase of 0.1% from the prior year quarter • Gross profit margin in Q1’26 decreased to 30.9% from 35.9% from the prior year quarter • Net loss was $(6.5)”
EMMA Emmaus Life Sciences, Inc.

Emmaus Life Sciences, Inc. reported three months ended March 31, 2026 results: revenue $2.0 million, net income $3.3 million, EPS $0.05 basic net loss per share.

“Net revenues for the three months ended March 31, 2026 were $2.0 million, compared to $2.4 million in the same period in 2025.”
ENSC Ensysce Biosciences, Inc.

Ensysce Biosciences, Inc. reported financial results for first quarter ended March 31, 2026.

“On May 15, 2026, Ensysce Biosciences, Inc. (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended March 31, 2026.”
BCG Binah Capital Group, Inc.

Binah Capital Group, Inc. reported first quarter ended March 31, 2026 results: revenue Total Revenue of $48.7 million, net income Net Income to $1.9 Million, EPS GAAP diluted EPS was $0.09.

“- - Increased Net Income to $1.9 Million from $1.0 million in the Prior Year - - Increased EBITDA [*] to $3.3 Million from $2.2 Million in the Prior Year - - Total Revenue of $48.7 million similar to $48.9 million in prior year period - New York – May 15, 2026 – Binah Capital Group, Inc. (“Binah”, “Binah Capital” or the “Company”) (NASDAQ: BCG; BCGWW), a leading”
LTCH Latch, Inc.

Latch, Inc. reported first quarter ended March 31, 2026 results: revenue $15.7 million, net income $(5.9) million.

“Quarter 2026 Highlights ● Software revenue increased by 19.1% year-over-year to $6.1 million, driven by continued subscription growth on the DOOR platform. ● Total revenue was $15.7 million, essentially flat year-over-year, as software and hardware growth offset a reduction in services activity. ● Operating expenses decreased by 25.6% year-over-year to $13.8”
GNLN Greenlane Holdings, Inc.

Greenlane Holdings, Inc. reported the first quarter ended March 31, 2026 results: revenue approximately $0.4 million, net income $(18.4) million, or $(4.49) per Class A share, EPS $(4.49) per Class A share.

“share at March 31, 2026, from approximately 86 units of BERA per Class A share at December 31, 2025, an increase of approximately 44%. The Company also recognized approximately $0.4 million of staking revenue from participation in Berachain’s Proof of Liquidity (“PoL”) consensus mechanism. During the first quarter 2026, Greenlane Subsidiary Inc., a wholly-owned”
PSTV PLUS THERAPEUTICS, INC.

PLUS THERAPEUTICS, INC. reported the first quarter ended March 31, 2026 results: revenue $1.0 million, net income $6.9 million, or $1.05 per basic share, EPS $1.05 per basic share. Guidance reaffirmed.

“2026 public offering, partially offset by operating expenditures during the quarter and paydown of the investor liability at December 31, 2025 of $4.5 million • Recognized $1.0 million in revenue in the first quarter of 2026, including grant revenue from CPRIT for the advancement of REYOBIQ in LM and CNSide diagnostic billings, compared to $1.1 million in the”
XPON Expion360 Inc.

Expion360 Inc. reported the first quarter ended March 31, 2026 results: revenue $1.6 million, net income Net loss in the first quarter of 2026 totaled $1.8 million.

“Net sales for the three months ended March 31, 2026 totaled $1.6 million”
HSDT Solana Co

Solana Co reported the quarter ended March 31, 2026 results: revenue $3.6 million, net income $99.8 million, or a loss of $1.30 per basic and diluted common share.

“HSDT) (the “Company” or “HSDT”), a publicly listed company, today announced results for the quarter ended March 31, 2026. First Quarter Recent Business Updates ● Generated $3.6 million in revenue in the first quarter of 2026, with the increase primarily driven by the Company’s SOL earning staking yield ● Executed approximately $3.5 million in share repurchases”
SKLZ Skillz Inc.

Skillz Inc. reported first quarter ended March 31, 2026 results: revenue $29.1 million, net income $10.9 million.

“to players worldwide, today reported unaudited financial results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Highlights (Unaudited): • Revenue of $29.1 million • Gross profit of $25.5 million • Net loss of $10.9 million • Adjusted EBITDA 1 loss of $12.8 million • Paying monthly active users (PMAUs) 2 of 128 thousand • Average revenue”
RANI Rani Therapeutics Holdings, Inc.

Rani Therapeutics Holdings, Inc. reported the first quarter ended March 31, 2026 results: revenue $1.7 million, net income $8.0 million.

“and license agreement with Chugai, to be sufficient to fund its operations into the fourth quarter of 2027. • Contract revenue for the three months ended March 31, 2026 were $1.7 million, compared to $0.2 million for the same period in 2025. The increase of $1.5 million was primarily attributable to the collaboration and license agreement with Chugai. • Research”
ZDPY Zoned Properties, Inc.

Zoned Properties, Inc. reported the three months ended March 31, 2026 results: revenue $1,172,436, net income a net loss of $54,660 or $0.00 per fully diluted share, EPS $0.00 per fully diluted share.

“today announced its financial results for the three months ended March 31, 2026. Selected Financial Highlights for the Three Months Ended March 31, 2026: ● Total revenues were $1,172,436 for the quarter ended March 31, 2026, compared to total revenues of $974,552 for the quarter ended March 31, 2025, an increase of 20.3%. ● Operating expenses were $1,045,868”
LTRN Lantern Pharma Inc.

Lantern Pharma Inc. reported financial results for the first quarter ended March 31, 2026.

“On May 15, 2026, Lantern Pharma Inc. (the “Company”) will issue a press release announcing its financial results for the first quarter ended March 31, 2026.”
LGMK LogicMark, Inc.

LogicMark, Inc. reported first quarter ended March 31, 2026 results: revenue $3.2 million, net income $1.5 million, or $1.68 per basic and diluted share, EPS $1.68 per basic and diluted share.

“safety economy, today announced financial and operational results for the first quarter ended March 31, 2026. Financial Highlights ● First quarter 2026 revenue increased 24% to $3.2 million compared to the same period last year. Revenue has increased year-over-year in seven of the last eight quarters. ● Gross margin expanded 610 basis points to 69.6%, up from 63.5%”
JOB GEE Group Inc.

GEE Group Inc. reported fiscal 2026 second quarter and year-to-date periods ended March 31, 2026 results: revenue 19.5 million for the three-month period; 40.0 million for the six-month period, net income 14 thousand for the three-month period; -136 thousand for the six-month period, EPS 0.00 per diluted share for the three-month period; -0.00 per diluted share for the six-month period.

“direct hire placements will be solid and increase for the remainder of the fiscal year. 1 · Consolidated revenues for the three and six-month periods ended March 31, 2026 were $19.5 million and $40.0 million, respectively, down 20% and 18% over the comparable fiscal 2025 periods. These decreases are mainly attributable to the acquisition of one of our higher volume,”
NXXT NEXTNRG, INC.

NEXTNRG, INC. reported the first quarter ended March 31, 2026 results: revenue $21,059,130, net income Net Loss $(10,766,492).

“set forth by specific reference in such a filing. --- EX-99.1 (EX-99.1) --- NextNRG Reports First Quarter 2026 Financial Results Revenue Increased 29% Year-Over-Year to $21.1 Million While Gross Profit More Than Tripled Interest Expense Declined 80% as Company Advances Microgrid Pipeline and Optimizes Fueling Operations MIAMI, FL - May 15, 2026 - NextNRG,”
EP EMPIRE PETROLEUM CORP

EMPIRE PETROLEUM CORP reported financial results for first quarter 2026.

“Empire Petroleum Corporation (the "Company") issued a press release announcing its financial and operating results for the first quarter 2026.”
HYFM HYDROFARM HOLDINGS GROUP, INC.

HYDROFARM HOLDINGS GROUP, INC. reported first quarter ended March 31, 2026 results: revenue $28.5 million, net income $14.6 million, EPS $(3.07) per diluted share.

“agriculture, today announced financial results for its first quarter ended March 31, 2026 . Comparison of First Quarter vs. Prior Year Period: • Net sales decreased to $28.5 million compared to $40.5 million. • Gross Profit Margin decreased to 6.4% of net sales compared to 17.0%. • Adjusted Gross Profit Margin (1) decreased to 15.8% of net sales compared to”
ANVS Annovis Bio, Inc.

Annovis Bio, Inc. reported first quarter ended March 31, 2026 results: EPS $0.63 basic and diluted net loss per common share.

“Annovis reported a $0.63 basic and diluted net loss per common share for the three months ended March 31, 2026, compared to a $0.32 basic and diluted net loss per common share for the three months ended March 31, 2025.”
VYCO VYCOR MEDICAL INC

VYCOR MEDICAL INC reported the three months ended March 31, 2026 results: revenue $458,540.

“the traditional blade retractor group, implying safer tumor resection using VBAS. Financial Results For the three months ended March 31, 2026, the Company reported revenue of $458,540, an increase of $22,162 (or 5%) over the 2025 period. The Vycor Medical division (VBAS) generated revenue of $440,441, an increase of $21,921 (or 5%) over the 2025 period. Most of”
LUVU Luvu Brands, Inc.

Luvu Brands, Inc. reported the third fiscal quarter ended March 31, 2026 results: revenue $6.55 million, net income $174,000.

“while maintaining our commitment to product quality and customer experience.” Strong Revenue Performance Net sales for the three months ended March 31, 2026, increased 12.0% to $6.55 million, compared to $5.85 million in the prior‐year period. Key product categories and channels drove improved demand results and expanded our customer base. For the nine‐month period,”
ROC Rank One Computing Corp

Rank One Computing Corp reported the first quarter ended March 31, 2026 results: revenue $2.5 million, net income Net loss was $3.0 million, EPS ($0.18).

“Net loss was $3.0 million, compared to $0.7 million in the first quarter of 2025.”
PROK PROKIDNEY CORP.

PROKIDNEY CORP. reported the first quarter ended March 31, 2026 results: net income Net loss before noncontrolling interest was $42.6 million.

“ProKidney Corp. (the "Company") issued a press release to announce its financial results for the quarter ended March 31, 2026.”
RBC RBC Bearings INC

RBC Bearings INC reported full year fiscal 2026 results: revenue $1,870.9 million, net income $287.6 million.

“% 28.7 % Diluted EPS $ 2.89 $ 3.62 $ 2.30 $ 2.83 25.7 % 27.9 % (1) Results exclude items in reconciliation below. Fiscal 2026 Financial Highlights ● Fiscal 2026 net sales of $1,870.9 million increased 14.3% over last year, Aerospace & Defense up 32.9% and Industrial up 3.8%. ● Gross margin of 44.4% for fiscal 2026 compared to 44.4% last year; Adjusted gross margin of”
RBC RBC Bearings INC

RBC Bearings INC reported the quarter ended March 28, 2026 results: revenue $518.0 million, net income $91.7 million.

“aerospace and defense markets, today reported results for the fourth quarter and full year fiscal 2026. Fourth Quarter Financial Highlights ● Fourth quarter net sales of $518.0 million increased 18.3% over last year, Aerospace & Defense up 41.2% and Industrial up 5.5%. ● Gross margin of 44.4% for the fourth quarter of fiscal 2026 compared to 44.2% last year;”
WFCF Where Food Comes From, Inc.

Where Food Comes From, Inc. reported first quarter ended March 31, 2026 results: net income $92,000, EPS $0.02 per diluted share.

“Total revenue in the first quarter ended March 31, 2026, increased to $5.4 million from $5.3 million.”
MHH Mastech Digital, Inc.

Mastech Digital, Inc. reported first quarter ended March 31, 2026 results: revenue $41,083, net income $264, EPS $0.02.

“31, December 31, (In thousands, except per share data) 2026 2025 2025 Revenues Data & AI Segment $ 12,584 $ 15,997 $ 14,409 Talent Segment 28,499 32,319 31,052 Consolidated $ 41,083 $ 48,316 $ 45,461 Gross Profit Data & AI Segment $ 4,684 $ 6,034 $ 5,902 Talent Segment 6,341 6,858 6,981 Consolidated $ 11,025 $ 12,892 $ 12,883 Gross Margin Data & AI Segment”

Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.